基因组甲基化修饰和糖尿病病:潜在的分子机制和治疗方法 (综述)
Peng Qu1, Lanfang Li1, Qi Jin2
1Institute of Clinical Medical Sciences, China‑Japan Friendship Hospital, Beijing 100029, P.R. China.
International journal of molecular medicine
|September 20, 2024
概括
基斯甲基化变化是糖尿病病 (DKD) 发展的关键. 针对这些表观遗传变化提供了一种有前途的新方法来治疗DKD,减少损伤和蛋白尿.
科学领域:
- 表观遗传学和分子生物学
- 科和脏疾病研究研究
背景情况:
- 糖尿病病 (DKD) 是慢性病和末期病的主要原因,其特征是蛋白尿和减少膜过率.
- 目前对DKD的治疗方法不足,其患病率上升的证据表明,需要新的治疗策略.
研究的目的:
- 审查基因素甲基化变化的作用在糖尿病病 (DKD) 的致病性.
- 总结一下这些表观遗传修饰对DKD关节细胞的影响.
- 突出向激素甲基化的治疗潜力,以改善DKD结果.
主要方法:
- 对糖尿病脏病中组织素甲基化现有文献的系统综述.
- 分析基因组甲基化变化如何影响细胞中的基因转录和染色质结构.
- 在DKD模型中评估研究研究治疗干预措施的评估,以向激素甲基化.
主要成果:
- 在DKD患者中观察到基因组甲基化模式的改变,影响了遗传和环境因素之间的相互作用.
- 这些表观遗传修改与DKD中组织学损伤,纤维化和蛋白尿的进展有关.
- 向组织素甲基化显示出改善与DKD相关的病理的潜力.
结论:
- 基斯甲基化是糖尿病病的发展和进展中的关键表观遗传调节剂.
- 向特定的基因组甲基化修饰是一种有希望的新疗法,可以阻止DKD的进展并改善结局.
相关概念视频
Pathophysiology of Diabetes
900
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
900
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Management and Pharmacotherapy
244
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
244
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Symptoms, Diagnosis, and Complications
516
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
516
Histone Modification
3.4K
3.4K


